SCHEMBL2806858

SCHEMBL2806858

CC(C)(C)C(ONC(=O)O)c1nc2cnc3ccccc3c2s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.39
TLR7 Q9NYK1 4/20 0.38
TLR8 Q9NR97 3/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.35
TACR3 P29371 1/20 0.35
NPC1 O15118 1/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 1/20 0.34
DUSP10 Q9Y6W6 1/20 0.33
HPGD P15428 1/20 0.33
TOP2A P11388 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
POLB P06746 1/20 0.33
PKM P14618 1/20 0.33
PRNP P04156 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807847 0.83 TLR7 (0.59) TP53TLR7TLR8MEN1KMT2A
SCHEMBL1528340 0.73 TLR8 (0.56) TP53TLR7TLR8MEN1KMT2A
SCHEMBL4970650 0.73 KMT2A (0.40) TP53TLR7TLR8MEN1KMT2A
SCHEMBL7959642 0.71 L3MBTL1 (0.44) KMT2AALDH1A1KDM4EMAPT
SCHEMBL30539927 0.70 TLR8 (0.43) TLR7TLR8TACR3GAAHPGD
SCHEMBL2806860 0.69 TLR8 (0.37) TP53TLR7TLR8MEN1KMT2A
SCHEMBL1527997 0.68 TLR7 (0.53) TLR7TLR8KMT2AALDH1A1NPC1
SCHEMBL26601331 0.68 LMNA (0.34) TP53TLR7TLR8PKMSMN1; SMN2
SCHEMBL26601327 0.68 LMNA (0.34) TP53TLR7TLR8PKMSMN1; SMN2
Hydrochloric Acid SCHEMBL10689240 0.67 TLR7 (0.51) TLR7TLR8KMT2AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378102-B2 Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-02-19 US disclosed
US-20100240693-A1 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods COLEY PHARMACEUTICAL GROUP, INC (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240693-A1 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods IL4, IL2, TH TP53 383/4885TLR7 43/4885TLR8 203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.